Page last updated: 2024-11-08

dihydroresveratrol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dihydroresveratrol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dihydroresveratrol : A stilbenol that is 1,1'-ethane-1,2-diyldibenzene with hydroxy groups at positions 1, 3 and 4'. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID185914
CHEMBL ID111234
CHEBI ID4582
SCHEMBL ID716856
MeSH IDM0540717

Synonyms (38)

Synonym
nsc-723534
nsc723534
dihydroresveratrol
58436-28-5
LMPK13090035
3,4'',5-trihydroxybibenzyl
5-[2-(4-hydroxy-phenyl)-ethyl]-benzene-1,3-diol
bdbm50085531
alpha,beta-dihydro-3,40,5-trihydroxystilbene
5-(4-hydroxyphenethyl)benzene-1,3-diol
5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol
RE2 ,
DB08466
chebi:4582 ,
dihydro-resveratrol
CHEMBL111234 ,
3,4',5-trihydroxybibenzyl
cby43ay0tt ,
unii-cby43ay0tt
1,3-benzenediol, 5-(2-(4-hydroxyphenyl)ethyl)-
S6927
SCHEMBL716856
3FTU
a, b-dihydroresveratrol
3,5,4'-trihydroxybibenzyl
151363-17-6
AKOS030555676
Q5276414
SY232649
FT-0756540
mfcd25973128
BS-17153
5-(2-(4-hydroxyphenyl)ethyl)benzene-1,3-diol
butanamide, 4-amino-n-ethyl-, monohydrochloride
DTXSID60973983
HY-N3755
CS-0024161
alpha,beta-dihydroresveratrol

Research Excerpts

Overview

Dihydroresveratrol is a metabolite of trans-resver atrol. It is formed in the intestine by the hydrogenation of the double bond by microflora.

ExcerptReferenceRelevance
"Dihydroresveratrol is a metabolite of trans-resveratrol formed in the intestine by the hydrogenation of the double bond by microflora. "( Determination of dihydroresveratrol in rat plasma by HPLC.
Alfaras, I; Juan, ME; Planas, JM, 2010
)
2.14

Effects

ExcerptReferenceRelevance
"Dihydroresveratrol has been demonstrated to possess a wide spectrum of bioactivities, such as anti-oxidant and anti-inflammatory effects. "( Detection and structural characterization of the metabolites of dihydroresveratrol in rats by liquid chromatography coupled to high-resolution tandem mass spectrometry.
Hu, XM; Ji, QG; Ma, MH; Nian, H; Xu, XH; Zhang, YJ, 2021
)
2.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
xenobiotic metaboliteAny metabolite produced by metabolism of a xenobiotic compound.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
stilbenolAny stilbenoid with at least one phenolic group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (21)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Chain A, Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)247.0000212.00001,235.33332,000.0000AID977608
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)IC50 (µMol)30.00000.05102.47257.5000AID1467685
Leukotriene A-4 hydrolaseHomo sapiens (human)IC50 (µMol)196.00000.00051.28547.6500AID420374; AID420375
AromataseHomo sapiens (human)IC50 (µMol)50.00000.00001.290410.0000AID642091
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)30.00000.00033.166210.0000AID1467684
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
NAD(P)H dehydrogenase [quinone] 1Mus musculus (house mouse)CD50.00000.00020.23892.6500AID642329
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (40)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
proteolysisLeukotriene A-4 hydrolaseHomo sapiens (human)
lipid metabolic processLeukotriene A-4 hydrolaseHomo sapiens (human)
response to zinc ionLeukotriene A-4 hydrolaseHomo sapiens (human)
leukotriene biosynthetic processLeukotriene A-4 hydrolaseHomo sapiens (human)
protein metabolic processLeukotriene A-4 hydrolaseHomo sapiens (human)
peptide catabolic processLeukotriene A-4 hydrolaseHomo sapiens (human)
response to peptide hormoneLeukotriene A-4 hydrolaseHomo sapiens (human)
type I pneumocyte differentiationLeukotriene A-4 hydrolaseHomo sapiens (human)
negative regulation of chronic inflammatory responseAromataseHomo sapiens (human)
steroid biosynthetic processAromataseHomo sapiens (human)
estrogen biosynthetic processAromataseHomo sapiens (human)
androgen catabolic processAromataseHomo sapiens (human)
syncytium formationAromataseHomo sapiens (human)
negative regulation of macrophage chemotaxisAromataseHomo sapiens (human)
sterol metabolic processAromataseHomo sapiens (human)
female genitalia developmentAromataseHomo sapiens (human)
mammary gland developmentAromataseHomo sapiens (human)
uterus developmentAromataseHomo sapiens (human)
prostate gland growthAromataseHomo sapiens (human)
testosterone biosynthetic processAromataseHomo sapiens (human)
positive regulation of estradiol secretionAromataseHomo sapiens (human)
female gonad developmentAromataseHomo sapiens (human)
response to estradiolAromataseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (21)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
RNA bindingLeukotriene A-4 hydrolaseHomo sapiens (human)
aminopeptidase activityLeukotriene A-4 hydrolaseHomo sapiens (human)
epoxide hydrolase activityLeukotriene A-4 hydrolaseHomo sapiens (human)
leukotriene-A4 hydrolase activityLeukotriene A-4 hydrolaseHomo sapiens (human)
protein bindingLeukotriene A-4 hydrolaseHomo sapiens (human)
peptidase activityLeukotriene A-4 hydrolaseHomo sapiens (human)
zinc ion bindingLeukotriene A-4 hydrolaseHomo sapiens (human)
tripeptide aminopeptidase activityLeukotriene A-4 hydrolaseHomo sapiens (human)
metalloaminopeptidase activityLeukotriene A-4 hydrolaseHomo sapiens (human)
iron ion bindingAromataseHomo sapiens (human)
steroid hydroxylase activityAromataseHomo sapiens (human)
electron transfer activityAromataseHomo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenAromataseHomo sapiens (human)
oxygen bindingAromataseHomo sapiens (human)
heme bindingAromataseHomo sapiens (human)
aromatase activityAromataseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (12)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
extracellular regionLeukotriene A-4 hydrolaseHomo sapiens (human)
nucleoplasmLeukotriene A-4 hydrolaseHomo sapiens (human)
cytosolLeukotriene A-4 hydrolaseHomo sapiens (human)
extracellular exosomeLeukotriene A-4 hydrolaseHomo sapiens (human)
tertiary granule lumenLeukotriene A-4 hydrolaseHomo sapiens (human)
ficolin-1-rich granule lumenLeukotriene A-4 hydrolaseHomo sapiens (human)
cytosolLeukotriene A-4 hydrolaseHomo sapiens (human)
nucleusLeukotriene A-4 hydrolaseHomo sapiens (human)
endoplasmic reticulumAromataseHomo sapiens (human)
endoplasmic reticulum membraneAromataseHomo sapiens (human)
membraneAromataseHomo sapiens (human)
endoplasmic reticulumAromataseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (47)

Assay IDTitleYearJournalArticle
AID1467686Inhibition of human TRPA1 expressed in HEK293 cells assessed as decrease in AITC-induced calcium influx at 10 uM preincubated for 6 mins followed by AITC addition measured for 1 min by Fluo-4 dye-based assay relative to control2017Bioorganic & medicinal chemistry letters, 07-15, Volume: 27, Issue:14
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
AID1486518Inhibition of acid-induced wild type transthyretin (unknown origin) aggregation expressed in Escherichia coli pre-incubated for 30 mins before acid addition and further incubated for 72 hrs at 37 degC under dark conditions by UV-Vis spectrophotometry2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
AID1467685Inhibition of human TRPA1 expressed in HEK293 cells assessed as decrease in AITC-induced calcium influx preincubated for 6 mins followed by AITC addition measured for 1 min by Fluo-4 dye-based assay2017Bioorganic & medicinal chemistry letters, 07-15, Volume: 27, Issue:14
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
AID399546Spasmolytic activity in guinea pig ileum assessed as inhibition of spontaneous contraction relative to papaverine2004Journal of natural products, Feb, Volume: 67, Issue:2
Spasmolytic effects, mode of action, and structure-activity relationships of stilbenoids from Nidema boothii.
AID642339Antioxidant activity assessed as DPPH free radical scavenging activity at 400 uM after 30 mins by spectrophotometry2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.
AID420374Inhibition of peptidase activity of human recombinant LTA4H expressed in Escherichia coli BL21-AI/pRARE2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.
AID400271Blockade of delayed rectifier potassium channel in mouse rat hybrid F11 cells at 90 uM by whole-cell patch clamp technique2004Journal of natural products, Mar, Volume: 67, Issue:3
Resveratrol derivatives and their role as potassium channels modulators.
AID517124Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, Oct-15, Volume: 20, Issue:20
Dihydro-resveratrol--a potent dietary polyphenol.
AID420376Inhibition of ionomycin-stimulated LTB4 production in human whole blood treated 15 mins prior to ionomycin challenge measured after 30 mins of stimulation by enzyme-linked immunosorbent assay2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.
AID517127Cytotoxicity against human BT474 cells after 48 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, Oct-15, Volume: 20, Issue:20
Dihydro-resveratrol--a potent dietary polyphenol.
AID1238829Retention time of the compound in C57BL/6J mouse urine treated with RAH at 200 mg/kg, ig by HPLC-CEAD analysis2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
Novel Resveratrol-Based Aspirin Prodrugs: Synthesis, Metabolism, and Anticancer Activity.
AID1347858Inhibition of tyrosinase in mouse B16 cells assessed as effect on alpha-MSH-induced melanin formation at 25 uM after 24 hrs relative to control2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and evaluation of novel dihydrostilbene derivatives as potential anti-melanogenic skin-protecting agents.
AID132501Inhibitory activity against nitric oxide production in LPS-activated mouse peritoneal macrophages2000Bioorganic & medicinal chemistry letters, Feb-21, Volume: 10, Issue:4
Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages.
AID1486519Binding affinity to transthyretin in human blood plasma assessed as plasma binding selectivity by measuring stoichiometry of small molecule bound to TTR incubated for 24 hrs at 37 degC by RP-HPLC2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
AID1467684Agonist activity at human TRPA1 expressed in HEK293 cells assessed as induction of calcium influx at 30 uM after 6 mins by Fluo-4 dye-based assay2017Bioorganic & medicinal chemistry letters, 07-15, Volume: 27, Issue:14
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
AID1347860Growth inhibition of mouse B16 cells at 25 uM after 48 hrs by SRB assay relative to control2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and evaluation of novel dihydrostilbene derivatives as potential anti-melanogenic skin-protecting agents.
AID1347857Inhibition of tyrosinase in human A375 cells assessed as effect on alpha-MSH-induced melanin formation at 25 uM after 24 hrs relative to control2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and evaluation of novel dihydrostilbene derivatives as potential anti-melanogenic skin-protecting agents.
AID399545Spasmolytic activity in guinea pig ileum assessed as inhibition of spontaneous contraction2004Journal of natural products, Feb, Volume: 67, Issue:2
Spasmolytic effects, mode of action, and structure-activity relationships of stilbenoids from Nidema boothii.
AID517126Cytotoxicity against human K562 cells after 48 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, Oct-15, Volume: 20, Issue:20
Dihydro-resveratrol--a potent dietary polyphenol.
AID1347866Inhibition of alpha-MSH-induced reactive oxygen species generation in human A375 cells at 25 uM after 4 hrs by DCFDA staining-based fluorescence assay2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and evaluation of novel dihydrostilbene derivatives as potential anti-melanogenic skin-protecting agents.
AID400267Blockade of inward rectifier potassium channel in mouse rat hybrid F11 cells at 90 uM by whole-cell patch clamp technique2004Journal of natural products, Mar, Volume: 67, Issue:3
Resveratrol derivatives and their role as potassium channels modulators.
AID642091Inhibition of human aromatase using dibenzylfluorescein as substrate preincubated for 30 mins measured after 2 hrs by fluorimetry2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.
AID1347865Antioxidant activity assessed as ABTS radical scavenging activity at 25 uM after 15 mins2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and evaluation of novel dihydrostilbene derivatives as potential anti-melanogenic skin-protecting agents.
AID399549Binding affinity to bovine brain calmodulin by electrophoretic mobility assay in presence of calcium chloride2004Journal of natural products, Feb, Volume: 67, Issue:2
Spasmolytic effects, mode of action, and structure-activity relationships of stilbenoids from Nidema boothii.
AID1467689Inhibition of human TRPA1 expressed in HEK293 cells assessed as decrease in AITC-induced calcium influx at 30 uM preincubated for 6 mins followed by AITC addition measured for 1 min by Fluo-4 dye-based assay relative to resveratrol2017Bioorganic & medicinal chemistry letters, 07-15, Volume: 27, Issue:14
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
AID642330Induction of QR1-mediated cytoprotective activity in mouse Hepa-1c1c7 cells at 50 uM assessed as cell survival2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.
AID517125Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, Oct-15, Volume: 20, Issue:20
Dihydro-resveratrol--a potent dietary polyphenol.
AID420375Inhibition of hydrolase activity of human recombinant LTA4H expressed in Escherichia coli BL21-AI/pRARE assessed as LTB4 formation by tandem quadrupole mass spectrometry2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.
AID420373Solubility in methanol2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.
AID642337Inhibition of TNFalpha-activated NF-kappaB expressed in HEK293 cells at 50 uM by luciferase reporter gene assay2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.
AID642342Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production at 40 uM preincubated for 30 mins before LPS challenge measured after 24 hrs by Griess method2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.
AID1467690Agonist activity at human TRPA1 expressed in HEK293 cells assessed as induction of calcium influx at 30 uM after 6 mins by Fluo-4 dye-based assay relative to AITC2017Bioorganic & medicinal chemistry letters, 07-15, Volume: 27, Issue:14
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
AID463401Antioxidant activity assessed as concentration required to double citronellal oxidation half life by thermo-oxidation method relative to control2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
A theoretical study of the structure-radical scavenging activity of trans-resveratrol analogues and cis-resveratrol in gas phase and water environment.
AID642329Induction of QR1 activity in mouse Hepa-1c1c7 cells using MTT as substrate by spectrophotometry2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.
AID1347864Inhibition of alpha-MSH-induced TRP-2 expression in human A375 cells at 25 uM after 24 hrs by Western blot method2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and evaluation of novel dihydrostilbene derivatives as potential anti-melanogenic skin-protecting agents.
AID1070113Allosteric modulation of rat GABAA alpha1beta2gamma2S receptor expressed in Xenopus laevis oocytes assessed as potentiation of GABA-induced chloride ion current at holding potential -70 mV at 100 uM by two-microelectrode voltage clamp assay relative to GA2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Identification of dihydrostilbenes in Pholidota chinensis as a new scaffold for GABAA receptor modulators.
AID1238826Retention time of the compound in C57BL/6J mouse feces treated with RAH at 200 mg/kg, ig by HPLC-CEAD analysis2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
Novel Resveratrol-Based Aspirin Prodrugs: Synthesis, Metabolism, and Anticancer Activity.
AID642090Inhibition of human aromatase using dibenzylfluorescein as substrate at 50 uM preincubated for 30 mins measured after 2 hrs by fluorimetry2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.
AID1347863Inhibition of alpha-MSH-induced TRP-1 expression in human A375 cells at 25 uM after 24 hrs by Western blot method2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and evaluation of novel dihydrostilbene derivatives as potential anti-melanogenic skin-protecting agents.
AID642341Antiproliferative activity against human MCF7 cells after 72 hrs by SRB assay2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.
AID1467683Inhibition of human TRPA1 expressed in HEK293 cells assessed as decrease in AITC-induced calcium influx at 30 uM preincubated for 6 mins followed by AITC addition measured for 1 min by Fluo-4 dye-based assay relative to control2017Bioorganic & medicinal chemistry letters, 07-15, Volume: 27, Issue:14
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
AID1347859Growth inhibition of human A375 cells at 25 uM after 48 hrs by SRB assay relative to control2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis and evaluation of novel dihydrostilbene derivatives as potential anti-melanogenic skin-protecting agents.
AID1467682Inhibition of human TRPA1 expressed in HEK293 cells assessed as decrease in AITC-induced calcium influx at 3 uM preincubated for 6 mins followed by AITC addition measured for 1 min by Fluo-4 dye-based assay relative to control2017Bioorganic & medicinal chemistry letters, 07-15, Volume: 27, Issue:14
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
AID642334Induction of QR1 activity in mouse BPrc1 cells using MTT as substrate assessed as induction ratio by spectrophotometry relative to control2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.
AID642331Induction of QR1 activity in mouse TAOc1 mutant Hepa cells using MTT as substrate assessed as induction ratio by spectrophotometry relative to control2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.
AID642328Induction of QR1 activity in mouse Hepa-1c1c7 cells using MTT as substrate assessed as induction ratio by spectrophotometry relative to control2012Bioorganic & medicinal chemistry, Jan-01, Volume: 20, Issue:1
Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.
AID977608Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (14.29)29.6817
2010's24 (68.57)24.3611
2020's6 (17.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.17 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index5.48 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (5.71%)5.53%
Reviews1 (2.86%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (91.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]